On September 03, 2026, Core Scientific Inc CORZ shares rose 6.5% to a current price of $17.90, within a 52-week range of $13.14 to $30.46. This price movement follows a -21.6% decline over the past month, indicating volatility in the stock's performance.
- GF Valueâ„¢ verdict: Current price $17.90 vs. GF Valueâ„¢ of $11.77, indicating the stock is 52.1% overvalued.
- GF Scoreâ„¢: 47/100, reflecting an average performance across various metrics.
- Most notable signal: Insider activity shows net selling of $4.6M over the past 12 months, suggesting caution among insiders.
Is CORZ Overvalued or Undervalued?
Core Scientific Inc CORZ is currently trading at $17.90, which is significantly higher than its GF Valueâ„¢ estimate of $11.77. The GF Valueâ„¢ is GuruFocus's proprietary intrinsic-value estimate, which takes into account historical trading multiples, past business growth, and projected future performance. With a valuation that is 52.1% above its GF Valueâ„¢, it signals that the stock is significantly overvalued at this time. This overvaluation poses a risk for potential investors, as it could indicate a price correction in the future.
The GF Valuation label categorizes CORZ as significantly overvalued, which suggests that the current market price does not accurately reflect the company's underlying business fundamentals. Investors may want to proceed with caution, as overvalued stocks can often lead to disappointing returns if the market adjusts to more realistic valuations.
How Does CORZ's Valuation Compare to Its History?
| Metric | Current | Historical |
|---|---|---|
| P/E (TTM) | N/A | 26.4x |
| Forward P/E | 67.3x | N/A |
Currently, Core Scientific does not have a trailing twelve-month (TTM) P/E ratio available, making it difficult to conduct a direct comparison against its historical P/E median of 26.4x. However, the forward P/E of 67.3x indicates that the market is pricing in significant growth expectations. This high forward P/E suggests that the stock is trading at a premium compared to its historical averages, further aligning with the GF Valueâ„¢ verdict of overvaluation.
What Does CORZ's GF Scoreâ„¢ Tell Us?
The GF Scoreâ„¢ measures a stock's performance across multiple dimensions, including financial strength, profitability, growth potential, valuation, and momentum. Core Scientific's GF Scoreâ„¢ of 47/100 indicates an average performance, with notable strengths in growth and weaknesses in valuation and financial strength.
| Metric | Rating |
|---|---|
| GF Scoreâ„¢ | 47 |
| Financial Strength | 2/10 |
| Profitability | 4/10 |
| Growth | 9/10 |
| Valuation | 3/10 |
| Momentum | 0/10 |
Core Scientific's strongest area is its growth rank of 9/10, which indicates potential for future expansion. However, it faces challenges with a financial strength rating of just 2/10 and a low momentum rank of 0/10. These scores suggest that while the company has growth potential, its current financial health and momentum may not support a high valuation.
What Are Gurus and Insiders Doing with CORZ?
Currently, 8 gurus hold shares of Core Scientific, with 5 adding to their positions and 5 trimming their holdings in recent quarters. This mixed signal from institutional investors highlights a lack of consensus on the stock's future prospects. Additionally, insider activity over the last 12 months reveals that insiders have sold $5.1M worth of shares while only buying $0.5M, resulting in a net selling of $4.6M. This pattern of net selling may indicate a lack of confidence among insiders regarding the company's short-term performance.
What This Means for Investors
Based on the analysis, Core Scientific Inc CORZ is currently overvalued according to the GF Valueâ„¢ estimate, trading significantly above its intrinsic value. The combination of high valuation metrics, low financial strength, and mixed insider activity suggests cautious consideration for potential investors. For more detailed insights, visit the Core Scientific Inc (CORZ) stock page for further analysis and information.
Frequently Asked Questions
What is CORZ's GF Scoreâ„¢?
Core Scientific has a GF Scoreâ„¢ of 47/100, reflecting an average performance across various metrics.
Is CORZ overvalued or undervalued?
CORZ is currently overvalued, with a GF Valueâ„¢ estimate of $11.77 compared to its trading price of $17.90, indicating a significant premium.
What is CORZ's P/E ratio?
Core Scientific does not have a TTM P/E ratio available, but its forward P/E is 67.3x, indicating a high valuation relative to historical norms.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
